Friday, July 25, 2008

Vytorin increased risk of cancer 70%

"The 2,000-patient SEAS study found a roughly 70% increase in the risk of dying from cancer. But the Oxford analysis of the two ongoing studies, called IMPROVE-IT and SHARP, found about a 33% increase in the risk of dying from cancer, considered borderline in statistical significance."

Vytoring a 70% or 33% increase in cancer?

Stay tuned.

More in USA Today.

No comments: